Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
9.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmaceutical processors; operation of cannabis dispensing facilities. | Board of Pharmacy; pharmaceutical processors; cannabis dispensing facilities. Defines "cannabis dispensing facilities" and allows the Board of Pharmacy to issue up to five permits for cannabis dispensing facilities per health service area. The bill requires the Board to establish a ratio of one pharmacist for every six pharmacy interns, technicians, and technician trainees for pharmaceutical processors and cannabis dispensing facilities. The bill directs the Board of Pharmacy to require that, after processing and before dispensing cannabidiol oil and THC-A oil, a pharmaceutical processor make a sample available from each homogenized batch of product for testing at an independent laboratory located in Virginia that meets Board requirements. The bill requires that the Board promulgate regulations that include an allowance for the sale of devices for administration of dispensed products and an allowance for the use and distribution of inert product samples containing no cannabinoids for patient demonstration exclusively at the pharmaceutical processor or cannabis dispensing facility, and not for further distribution or sale, without the need for a written certification. The bill also requires the Board to adopt regulations for pharmaceutical processors that include requirements for (i) processes for safely and securely cultivating cannabis plants intended for producing cannabidiol oil or THC-A oil; (ii) a maximum number of marijuana plants a pharmaceutical processor may possess at any one time; (iii) the secure disposal of plant remains; (iv) dosage limitations, which shall provide that each dispensed dose of cannabidiol oil or THC-A not exceed 10 milligrams of tetrahydrocannabinol; and (v) a process for registering cannabidiol oil and THC-A oil products. The bill requires the Board of Pharmacy to promulgate required regulations within 280 days of the bill's enactment. | us/states/va | Virginia General Assembly | 2020 | SB 976 | Virginia SB 976 (2020) |
|
enacted |
|
5 | 45 | 10 | 2020-01-15 | 2020-04-22 | openstates | ocd-bill/3c0cc4e4-516b-4dcd-8198-72b6f5d9e244 | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB976 | 34c23d93e47080f06b8b0bd815fff502db40269f5e60b2f5b91e2b2a6b52d14f | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 976 (2020) — Pharmaceutical processors; operation of cannabis dispensing facilities.
Board of Pharmacy; pharmaceutical processors; cannabis dispensing facilities. Defines "cannabis dispensing facilities" and allows the Board of Pharmacy to issue up to five permits for cannabis dispensing facilities per health service area. The bill requires the Board to establish a ratio of one pharmacist for every six pharmacy interns, technicians, and technician trainees for pharmaceutical processors and cannabis dispensing facilities. The bill directs the Board of Pharmacy to require that, after processing and before dispensing cannabidiol oil and THC-A oil, a pharmaceutical processor make a sample available from each homogenized batch of product for testing at an independent laboratory located in Virginia that meets Board requirements. The bill requires that the Board promulgate regulations that include an allowance for the sale of devices for administration of dispensed products and an allowance for the use and distribution of inert product samples containing no cannabinoids for patient demonstration exclusively at the pharmaceutical processor or cannabis dispensing facility, and not for further distribution or sale, without the need for a written certification. The bill also requires the Board to adopt regulations for pharmaceutical processors that include requirements for (i) processes for safely and securely cultivating cannabis plants intended for producing cannabidiol oil or THC-A oil; (ii) a maximum number of marijuana plants a pharmaceutical processor may possess at any one time; (iii) the secure disposal of plant remains; (iv) dosage limitations, which shall provide that each dispensed dose of cannabidiol oil or THC-A not exceed 10 milligrams of tetrahydrocannabinol; and (v) a process for registering cannabidiol oil and THC-A oil products. The bill requires the Board of Pharmacy to promulgate required regulations within 280 days of the bill's enactment.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP1278) (committee substitute) — source
- Bill text as passed Senate and House (SB976ER) (committee substitute) — source
- Engrossed by Senate - committee substitute SB976S1 (committee substitute) — source
- Engrossed by Senate - committee substitute SB976S1 (committee substitute) — source
- Reenrolled bill text (SB976ER2) (committee substitute) — source
Votes
- VOTE: (87-Y 5-N) — 86–5 (pass) · lower
- House amendments agreed to by Senate (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Health, Welfare and Institutions with amendments (22-Y 0-N) — 22–0 (pass) · lower
- Subcommittee recommends reporting with amendment (5-Y 1-N) — 5–1 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Senate concurred in Governor's recommendation (39-Y 1-N) — 39–1 (pass) · upper
Sponsors
- David W. Marsden — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-15 Presented and ordered printed 20105207D
introduction - 2020-01-15 Referred to Committee on Education and Health
referral-committee - 2020-01-20 Assigned Education sub: Health Professions
referral-committee - 2020-02-06 Reported from Education and Health with substitute (15-Y 0-N)
committee-passage - 2020-02-06 Committee substitute printed 20107275D-S1
substitution - 2020-02-07 Constitutional reading dispensed (37-Y 0-N)
- 2020-02-10 Read second time
reading-2 - 2020-02-10 Reading of substitute waived
- 2020-02-10 Committee substitute agreed to 20107275D-S1
- 2020-02-10 Engrossed by Senate - committee substitute SB976S1
- 2020-02-10 Constitutional reading dispensed (39-Y 0-N)
- 2020-02-10 Passed Senate (39-Y 0-N)
passage - 2020-02-11 Impact statement from DPB (SB976S1)
- 2020-02-13 Placed on Calendar
- 2020-02-13 Read first time
reading-1 - 2020-02-13 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2020-02-18 Assigned HWI sub: Health Professions
referral-committee - 2020-02-21 House committee, floor amendments and substitutes offered
- 2020-02-21 Subcommittee recommends reporting with amendment (5-Y 1-N)
- 2020-02-25 House committee, floor amendments and substitutes offered
- 2020-02-25 Reported from Health, Welfare and Institutions with amendments (22-Y 0-N)
committee-passage - 2020-02-27 Read second time
reading-2 - 2020-02-28 Read third time
reading-3 - 2020-02-28 Committee amendments agreed to
- 2020-02-28 Engrossed by House as amended
- 2020-02-28 Passed House with amendments BLOCK VOTE (100-Y 0-N)
passage - 2020-02-28 VOTE: Block Vote Passage (100-Y 0-N)
- 2020-03-02 Passed by temporarily
- 2020-03-02 House amendments agreed to by Senate (40-Y 0-N)
- 2020-03-06 Enrolled
- 2020-03-06 Impact statement from DPB (SB976ER)
- 2020-03-06 Signed by President
- 2020-03-06 Signed by Speaker
- 2020-03-12 Enrolled Bill Communicated to Governor on March 12, 2020
- 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-11 Governor's recommendation received by Senate
- 2020-04-22 Senate concurred in Governor's recommendation (39-Y 1-N)
- 2020-04-22 House concurred in Governor's recommendation (87-Y 5-N)
- 2020-04-22 VOTE: (87-Y 5-N)
- 2020-04-22 Governor's recommendation adopted
- 2020-04-22 Reenrolled
- 2020-04-22 Reenrolled bill text (SB976ER2)
- 2020-04-22 Signed by President as reenrolled
- 2020-04-22 Signed by Speaker as reenrolled
- 2020-04-22 Enacted, Chapter 1278 (effective 7/1/20)
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/3c0cc4e4-516b-4dcd-8198-72b6f5d9e244. Confidence: reported (aggregated from official Virginia legislature records).